Pharma, Health Insurance
Products & Services, Manufacturers & Providers
NICE: Final draft guidance on Abraxane published
NICE issued final guidance on nab-paclitaxel for pancreatic cancer.
In an unexpected move, just before the end of 2011, ...
Improving expenditure efficiency has been, for a ver...
Your Portal Link to Mass Media Universe.
Valuable Quarterly Romanian Market Analysis.
Ask the analyst
Tailor-made advice for you